Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy
| Autor: | Markus Wiesneth, Hubert Schrezenmeier, Vanessa Schneider, Jochen Greiner, Konstanze Döhner, Hartmut Döhner, Liling Zhang, Marlies Götz, Ursula Botzenhardt, Markus Rojewski, S Hofmann, Lars Bullinger, T F E Barth |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Cancer Research
Myeloid medicine.medical_treatment Antigens CD34 medicine.disease_cause Antigen Antigens CD hemic and lymphatic diseases medicine Humans Mutation business.industry Receptors Interleukin-12 Nuclear Proteins Myeloid leukemia Hematology Immunotherapy medicine.disease ADP-ribosyl Cyclase 1 Interleukin-12 Leukemia Myeloid Acute Leukemia NPM1 Mutation medicine.anatomical_structure Oncology Immunology Neoplastic Stem Cells Stem cell business Nucleophosmin |
| Zdroj: | Leukemia. 28:1759-1762 |
| ISSN: | 1476-5551 0887-6924 |
| DOI: | 10.1038/leu.2014.116 |
| Popis: | Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|